Rights issue offer

Kia ora e te whānau Rua,

As Rua continues to grow and strengthen, we’re pleased to share an important update and an opportunity for our shareholders to be part of the next stage of our journey.

Today, we’re announcing a Rights Offer, giving all eligible shareholders the opportunity to purchase 1 new share for every 3 existing shares at an issue price of $0.025 per share. The offer aims to raise up to $2 million.

If the offer is fully subscribed, and alongside proceeds from the anticipated sale of our Gisborne property, Rua expects to be in a strong position to reach financial self-sustainability.

This offer comes at a pivotal time for Rua. We are now generating meaningful revenue across Germany, Australia, and Aotearoa New Zealand — with FY25 revenue of $1.9 million, up from $322,000 in FY24.

Sales for the first quarter of FY26 are already at record levels, and we’re forecasting continued growth, with expectations to exceed $3 million by FY26.

The funds raised through this offer will support working capital and marketing activities to help us expand our product range and strengthen our international presence, particularly in Germany, Australia, the UK, and Czechia.

We are proud of the progress Rua has made — built on innovation, integrity, and our deep commitment to whānau and community. We see this next phase as an opportunity to continue growing a sustainable, globally respected medicinal cannabis company grounded in Māori values and driven by purpose.

Details

For full details, including offer terms, key dates, and eligibility information, please visit the dedicated website:

www.shareoffer.co.nz/rua

or

www.ruabio.com/capital-raise-november-2025

If you have any questions, email us at info@ruabio.com

Thank you for your continued support

Ngā mihi nui,

Rua Bioscience


Next
Next

Introducing the Oleo Panacea Dry Herb Vaporiser